Search Results 641-650 of 17018 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The aim of the clinical trial is evaluate the EndoRotor®'s ability to completely remove areas of Barrett's metaplasia considered ...
About this study. The purpose of this study is to characterize a landscape of DNA alterations, RNA transcripts, and microbiome changes in resected tumors ...
Wangensteen L, Mohamed F, Oberhelman-Eaton SS, Averkamp NM, Kiernan JA, Selladurai RI, Bohn BA, Lai B, O'Grady J. A Strategy to Improve Hepatitis B Vaccine ...
About this study. The purpose of this study is to test if a rare variant in the osteocalcin protein may act as a gain of function mutation in this molecule.
Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...
The purpose of this study is to provide personally tailored dietary suggestions to participants based on the Personalized Prediction Engine (patent pending) ...
The purpose of this study is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) cancer- ...
The purpose of this study of sulfasalazine is to see how well it works in preventing acute diarrhea in patients with cancer who are undergoing pelvic radiation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.